Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS

Código QR

Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive-aged women. It is characterized by chronic anovulation, hyperandrogenism, and the presence of polycystic ovary in ultrasound examination. PCOS is specified by an increased number of follicles at all growing sta...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ewa Rudnicka, Michał Kunicki, Anna Calik-Ksepka, Katarzyna Suchta, Anna Duszewska, Katarzyna Smolarczyk, Roman Smolarczyk
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	AMH PCOS hyperandrogenism Biology (General) QH301-705.5 Chemistry QD1-999
Acceso en línea:	https://doaj.org/article/2e3a546ede3f41e0a171a4b05ae83f69
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Synergistic Regulatory Effect of Inhibin and Anti-Müllerian Hormone on Fertility of Mice
por: Xue Yu, et al.
Publicado: (2021)

Anti-Müllerian Hormone Related to Reproductive and Productive Longevity in Egyptian Buffaloes
por: Ghada H. Abdel- Rahman Hassan, et al.
Publicado: (2021)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran Y, et al.
Publicado: (2021)

Polycystic ovary syndrome - 80 years of research and new directions in the study (literature review)
por: L. V. Damdinova, et al.
Publicado: (2016)

Investigation of identity’s peculiarities of the women with PCOS
por: M. Y. Kuzmin, et al.
Publicado: (2018)

PCOS Phenotype in Unselected Populations Study (P-PUP): Protocol for a Systematic Review and Defining PCOS Diagnostic Features with Pooled Individual Participant Data
por: Sylvia Kiconco, et al.
Publicado: (2021)

A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS)
por: Raksha Rani, et al.
Publicado: (2022)

Hormonal Characteristics of Women Receiving Ovarian Tissue Transplantation with or without Endogenous Ovarian Activity
por: Vinnie Hornshøj Greve, et al.
Publicado: (2021)

A novel mutation of AMHR2 in two brothers with persistent Müllerian duct syndrome and their intracytoplasmic sperm injection outcome
por: Jianzheng Fang, et al.
Publicado: (2021)

MODERN CONCEPTS OF THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME (LITERATURE REVIEW)
por: O. V. Panarina, et al.
Publicado: (2017)

The peculiarities of oral cavity and its subjective estimation of women with PCOS
por: I. A. Igumnov, et al.
Publicado: (2018)

Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS
por: Bo Zheng, et al.
Publicado: (2021)

Diagnóstico del Síndrome de Ovario Poliquístico: nuevos fenotipos, nuevas incógnitas
por: Merino,Paulina, et al.
Publicado: (2009)

Tratamiento del hirsutismo con espironolactona y con espironolactona más dexametasona
por: Devoto C,Enzo, et al.
Publicado: (2000)

Short-Term Aerobic Exercise Did Not Change Telomere Length While It Reduced Testosterone Levels and Obesity Indexes in PCOS: A Randomized Controlled Clinical Trial Study
por: Victor Barbosa Ribeiro, et al.
Publicado: (2021)

Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero
por: RECABARREN,SERGIO E, et al.
Publicado: (2005)

Hiperandrogenismo avanzado en una mujer postmenopáusica: Caso clínico
por: Salman M,Patricio, et al.
Publicado: (2011)

Ulmus minor bark hydro-alcoholic extract ameliorates histological parameters and testosterone level in an experimental model of PCOS rats
por: Hoseinpour Mohammad Javad, et al.
Publicado: (2019)

Effects of Soy Isoflavones, Resistant Starch and Antibiotics on Polycystic Ovary Syndrome (PCOS)-Like Features in Letrozole-Treated Rats
por: Geethika S. G. Liyanage, et al.
Publicado: (2021)

Editorial: Current Innovations in Non-invasive Diagnoses and/or Surgical Treatments of Endometriosis
por: Jean Marc Ayoubi
Publicado: (2021)

Induction ovulation with use of low dose HMG in patients with Clomiphene Citrate resistant polycystic ovary syndrome (PCOs)
por: T Nazari, et al.
Publicado: (2003)

Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles
por: Lihua Sun, et al.
Publicado: (2018)

Features of the Functional State of the Hypophysis-Ovarian System and Processes of Lipid Peroxidation – Antioxidant Protection in Women with Hyperandrogenism of Ovary Genesis in the Early Reproductive Period
por: O. V. Krusko, et al.
Publicado: (2021)

Evaluación del efecto agudo de la administración de GnRH sobre la secreción de leptina en mujeres sanas e hiperandrogénicas.
por: Maliqueo Y,Manuel, et al.
Publicado: (2000)

Novel mechanisms underlying anti-polycystic ovary like syndrome effects of electroacupuncture in rats: suppressing SREBP1 to mitigate insulin resistance, mitochondrial dysfunction and oxidative stress
por: Peng,Yan, et al.
Publicado: (2020)

Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition
por: Luigi Barrea, et al.
Publicado: (2021)

Endometrial markers of polycystic ovary syndrome (literature review)
por: E. M. Sharifulin, et al.
Publicado: (2017)

CHARACTERISTICS OF PITUITARY-OPVARIAN-ADRENAL AXIS IN ADOLESCENT GIRLS WITH HYPERPROLACTINEMIA OF VARIOUS GENESIS
por: A. V. Labygina, et al.
Publicado: (2012)

Involvement of Transforming Growth Factor Beta Family Genes in Gonadal Differentiation in Japanese Eel, <i>Anguilla japonica,</i> According to Sex-Related Gene Expressions
por: Chien-Ju Lin, et al.
Publicado: (2021)

Pronounced Trace Element Variation in Follicular Fluids of Subfertile Women Undergoing Assisted Reproduction
por: Lilly Johanna Schmalbrock, et al.
Publicado: (2021)

Effect of satapushpa churnam with tila tailam in oligomenorrhea associated with polycystic ovarian syndrome
por: Jyothi Jacob, et al.
Publicado: (2021)

Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion
por: Irene Cimino, et al.
Publicado: (2016)

Interpretation and significance of the definition of anti-Mullerian hormone in the practice of juvenile gynaecologist
por: Zaira K. Kumykova, et al.
Publicado: (2021)

Features of Chronic Endometritis in Women of Reproductive Age with Polycystic Ovary Syndrome
por: E. M. Sharifulin, et al.
Publicado: (2021)

Changing environments during the Middle-Upper Palaeolithic transition in the eastern Cantabrian Region (Spain): direct evidence from stable isotope studies on ungulate bones
por: Jennifer R. Jones, et al.
Publicado: (2018)

Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study
por: Congcong Jin, et al.
Publicado: (2021)

Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review
por: Carvalho Laura M. L., et al.
Publicado: (2018)

Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers
por: Moran Friedman-Gohas, et al.
Publicado: (2021)

Nomogram of age-specific anti-Müllerian hormone levels in healthy Egyptian females.
por: Eman Ahmed El-Attar, et al.
Publicado: (2021)

Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis
por: Yongqian Chen, et al.
Publicado: (2021)